SANJEEV AHUJA: Open Payments
NPI 1770762015 · ALDEN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,179 in 147 payments from 24 companies in 2025. Trend: 2023 $1,339 · 2024 $1,460 · 2025 $2,179
Food & beverage: $2,114Education: $65
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $231 |
| Currax Pharmaceuticals LLC | 17 | $219 |
| Lilly USA, LLC | 16 | $206 |
| Corcept Therapeutics | 13 | $193 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $182 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $167 |
| ABBVIE INC. | 14 | $142 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Amgen Inc. | 6 | $100 |
| Axsome Therapeutics, Inc. | 4 | $82 |
Products named: CONTRAVE, Korlym, XIFAXAN, Kerendia, MOUNJARO, VRAYLAR, TRELEGY ELLIPTA, REXULTI.
Industry payments across NY — which companies pay providers there.
